iBio, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IBIO research report →
Companywww.ibioinc.com
iBio, Inc. , a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing.
- CEO
- Martin Brenner
- IPO
- 2008
- Employees
- 16
- HQ
- Bryan, TX, US
Price Chart
Valuation
- Market Cap
- $26.84M
- P/E
- -7.37
- P/S
- 89.47
- P/B
- 2.62
- EV/EBITDA
- 0.82
- Div Yield
- 0.00%
Profitability
- Gross Margin
- -160.00%
- Op Margin
- -7985.33%
- Net Margin
- -9202.00%
- ROE
- -53.86%
- ROIC
- -30.00%
Growth & Income
- Revenue
- $400.00K · 77.78%
- Net Income
- $-18,377,000 · 26.22%
- EPS
- $-1.75 · 73.08%
- Op Income
- $-18,602,000
- FCF YoY
- 18.35%
Performance & Tape
- 52W High
- $3.82
- 52W Low
- $0.56
- 50D MA
- $1.93
- 200D MA
- $1.61
- Beta
- 1.24
- Avg Volume
- 1.02M
Get TickerSpark's AI analysis on IBIO
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 18, 26 | Stoner Elizabeth | other | 60,000 |
| May 7, 26 | Stoner Elizabeth | other | 0 |
| Mar 26, 26 | Banjak Marc | buy | 1,434 |
| Mar 26, 26 | Banjak Marc | buy | 12,500 |
| Mar 19, 26 | Duran Felipe | buy | 24,835 |
| Mar 19, 26 | Brenner Martin | buy | 12,336 |
| Jan 28, 26 | Banjak Marc | other | 146,000 |
| Jan 28, 26 | Duran Felipe | other | 179,000 |
| Jan 28, 26 | Brenner Martin | other | 479,000 |
| Nov 20, 25 | Schimmelpennink Evert B. | other | 13,500 |
Our IBIO Coverage
We haven't published any research on IBIO yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate IBIO Report →